StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca statistics

64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Feb 19, 2026
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
-0.06%
10.8%
Float
1.55B
49M
Shares Held by Insiders
0.00%
11.6%
Shares Held by Institutions
52.1%
56.4%

MarginsIndustry

Gross Margin
81.9%
53.1%
Operating Margin
23.4%
-38.7%
Pretax Margin
21.1%
-11.6%
Profit Margin
17.4%
-31.6%
EBITDA Margin
23.4%
-27.7%
FCF Margin
20.0%
-9.56%

Returns on capitalIndustry

Return on Equity (ROE)
21.5%
-50.3%
Return on Assets (ROA)
8.96%
-40.6%
Return on Invested Capital (ROIC)
15.8%
-33.1%
Return on Capital Employed (ROCE)
16.3%
-38.0%

Financial positionIndustry

Current Ratio
0.89
3.30
Quick Ratio
0.61
2.39
Debt / Equity
0.59
0.49
Debt / EBITDA
2.15
3.15
Debt / FCF
2.51
4.65
Net Debt / EBITDA
1.79
1.97
Interest Coverage
8.11
-6.31

GrowthIndustry

Revenue Growth (YoY)
8.63%
6.82%
Net Income Growth (YoY)
45.3%
-14.4%
EPS Growth (YoY)
45.3%
-12.3%
FCF Growth (YoY)
18.4%
6.85%
Revenue Growth (3Y CAGR)
9.82%
2.25%
Revenue Growth (5Y CAGR)
17.2%
6.41%
EPS Growth (3Y CAGR)
45.8%
1.30%
EPS Growth (5Y CAGR)
21.8%
3.78%

EfficiencyIndustry

Asset Turnover
0.51
0.40
Inventory Turnover
1.59
2.73
Revenue Per Employee
$5.54M
$429.29K
Profits Per Employee
$964.62K
-$690.06K
Employee Count
10,600
75

Income statement (TTM)Industry

Revenue
$58.74B
$66.37M
Gross Profit
$48.11B
$120.78M
Operating Income
$13.74B
-$21.40M
Pretax Income
$12.40B
-$12.98M
Net Income
$10.23B
-$22.39M
EBITDA
$13.74B
-$17.04M
EPS (Diluted)
$6.54
-$0.76

Balance sheetIndustry

Total Debt
$29.49B
$116.91M
Net Cash (Debt)
-$24.60B
$17.80M
Net Cash Per Share
-$15.86
$0.80
Equity (Book Value)
$50.30B
$53.27M
Book Value Per Share
$32.43
$1.50
Tangible Book Value
-$8.61B
$26.82M
Working Capital
-$3.59B
$79.93M

Cash flow (TTM)Industry

Operating Cash Flow
$14.58B
-$12.35M
Capital Expenditures
-$2.81B
-$1.00M
Free Cash Flow
$11.77B
-$18.21M
FCF Per Share
$7.59
-$0.42

Dividends and yieldsIndustry

Dividend Per Share
$3.13
$0.83
Dividend Growth (YoY)
5.39%
2.37%
Years of Dividend Growth
2
0
Payout Ratio
48.6%
55.4%
FCF Payout Ratio
42.3%
43.7%

Taxes and interestIndustry

Interest Expense
$1.69B
$2.93M
Income Tax
$2.17B
$73.00K
Effective Tax Rate
17.5%
20.7%

Scores and fair valueIndustry

Graham Number
$69.08
$19.34
Piotroski F-Score
9
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodAZNS&P 500DifferenceAZN per yearS&P 500 per year
1 month-1.3%+0.6%−1.9 pts
3 months-2.9%+3.4%−6.3 pts
Year to date-9.9%+13.3%−23.2 pts
1 year-2.2%+16.6%−18.8 pts
3 years+34.2%+86.4%−52.2 pts+10.3%+23.1%
5 years+50.2%+81.9%−31.7 pts+8.5%+12.7%
10 years+249.9%+318.9%−69.0 pts+13.3%+15.4%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

3M AZN shares were sold short on Oct 30, 2026, down 7.7% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 52.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20263,032,797-7.7%3,257,5201.0
Oct 15, 20263,284,132+25.4%2,954,1871.1
Sep 30, 20262,618,811+25.4%2,810,3351.0
Sep 15, 20262,087,754-27.9%3,161,6711.0
Aug 31, 20262,895,178+53.0%3,255,8311.0
Aug 14, 20261,892,646+2.9%5,542,3101.0
Jul 31, 20261,838,477-27.4%2,534,3401.0
Jul 15, 20262,533,640+65.6%3,192,0741.0
Jun 30, 20261,530,055+15.3%2,010,7561.0
Jun 15, 20261,326,546-22.8%2,118,9081.0
May 29, 20261,719,165-20.5%1,783,5381.0
May 15, 20262,162,492+18.1%1,807,3241.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?